Objective
To prepare for new adolescent vaccinations by examining current use of adolescent outpatient health care visits throughout the United States.
Design
Cross-sectional analysis of visits.
Setting
Outpatient hospital- and office-based practices in the United States included in the 1994-2003 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey.
Participants
Adolescents ages 11 to 21 years (n = 63 529) with outpatient visits.
Main Outcome Measures
Type of physician seen for overall and preventive visits, visit trends over time, demographics of adolescents seen by pediatricians vs family physicians, and visit type during which a vaccine was provided.
Results
Late-adolescence females (18-21 years old) had the most overall visits, 36% of which were to obstetrician-gynecologists. Pediatricians were seen at most outpatient visits for adolescents 14 years or younger, with fewer visits for those older than 14 years. Family practitioners were seen at one quarter of all outpatient visits. Only 9% of all adolescent visits were for preventive care. Early adolescents (11-14 years old) had 3 times more preventive visits than late adolescents (P<.001). Pediatricians were more likely to see adolescents who were younger, male, black, and urban and were more likely to be seen for preventive visits compared with family physicians (P<.001 for all). Altogether, 80%, 70%, and 64% of visits that included measles-mumps-rubella, hepatitis B, and diphtheria-tetanus vaccinations, respectively, were for preventive care.
Conclusions
On the basis of current utilization patterns, adolescent vaccinations should be delivered during early or middle adolescence. If vaccines are to be provided to older adolescent females, involvement of obstetrician-gynecologists in vaccine delivery is critical.
Immunizations have been called one of the greatest public health successes of the past century.1 In the past decade alone, rates of varicella infection have decreased by 81%,2 and invasive Streptococcus pneumoniae has declined markedly among children and adults.3-6
Although immunizations have been a long-standing focus of the preventive care of young children, they have not been a major component of adolescent preventive care, largely because there were few vaccines to offer adolescents. Recently, strategies for enhancing adolescent preventive services have been promulgated, including the Guidelines for Adolescent Preventive Services and Bright Futures, which recommend screening adolescents for a multitude of behaviors and risk factors annually.7-10 Although immunizations comprise only a small component of these guidelines, newly licensed adolescent vaccines, including meningococcal conjugate,11 pertussis booster,12,13 and human papillomavirus vaccines, as well as future vaccines for herpes simplex virus and ultimately human immunodeficiency virus, heighten the need to rethink adolescent vaccination delivery in the context of comprehensive preventive care. The epidemiologic features and pathogenesis of these diseases are the primary drivers for adolescent vaccination; all vaccines should be delivered either when immunity from prior immunization wanes or before adolescents are most at risk of acquiring one of these infections. However, given that utilization plays a definitive role in the practicality of vaccination delivery, it is important to understand health care utilization patterns for teens.
Many adolescents seek care at a variety of locations, whereas others lack comprehensive care.14-16 Prior studies have examined those adolescents who receive no health care. Results vary across data sets, but studies tend to show that black adolescents receive less primary care than white adolescents17 and that one sixth to one third of all adolescents do not see a physician within a year.14,18 The content of visits is variable, and visits among adolescents can be erratic, affecting the continuity and quality of adolescent preventive care.16,19-23 The advent of new vaccines for adolescents demands greater understanding of current patterns of care to target new vaccine implementation strategies and to evaluate their success.
Prior studies have not examined the role these patterns of health care might play in the implementation of new adolescent vaccines. Our study assessed current adolescent utilization nationally to help identify the following: (1) types of health care professionals who currently serve adolescents and will likely deliver vaccinations, (2) demographic differences between adolescents seen by pediatricians and those seen by family physicians, and (3) types of visits (eg, preventive or other) during which vaccines are currently administered. Understanding current patterns of adolescent visits and vaccinations can direct educational strategies of public health organizations and professional societies and can help immunization policymakers in targeting certain age groups and practice-level interventions to optimize the receipt of needed adolescent vaccines.
We performed a cross-sectional analysis of visits to both office-based physicians and hospital outpatient departments included each year in the annual National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS). Ten years of data from 1994 to 2003 were analyzed. Combining both surveys covers most outpatient visits across the United States, not including those to pathologists, anesthesiologists, radiologists, or federally employed physicians.24 In addition to traditional private offices, the NAMCS and NHAMCS include hospital clinics, family planning clinics, and mental health care centers. We combined a decade of data from both sources to enhance sample size (particularly for preventive visits) and to assess secular trends. These surveys use a patient encounter as the sampling unit and are weighted to be nationally representative; detailed descriptions are reported elsewhere.25,26 For both surveys, physicians or their staff complete a 1-page questionnaire at the time of each patient visit. For the NAMCS, physicians record information on visits made during a randomly selected 1-week period. For the NHAMCS, hospital staff or physicians at each hospital outpatient department complete a form for a sample of patients during a 4-week period. Visit-specific data include patient demographics, International Classification of Diseases, Ninth Revision (ICD-9)27 codes, physician specialty, and vaccinations provided. Visits to emergency departments were excluded from this analysis. The study was approved by the institutional review board at the University of Rochester.
We examined age-specific health care utilization across the entire age spectrum of adolescents (11-21 years old). For each age group and sex, we determined the type of health care professional seen for all visits and for preventive visits and the type of visit when a vaccination was given. We also examined the type of health care professional seen over time for secular trends and determined demographic differences in visits to pediatricians and family physicians. For both surveys, data are collected during a short period in each office, and preventive visits are unlikely to occur more than once per year, so it is unlikely that an individual could undergo sampling more than once. We used Health Plan Employer Data and Information Set28 definitions to identify preventive care visits, which included the following ICD-9 codes: V20.2, V70.0, V70.3, V70.5, V70.6, V70.8, and V70.9. Categories with fewer than 30 unweighted visits are not reported, since such data are not considered reliable.29 Family practice physicians and internists were combined into 1 subset for analyses of preventive visits because of small sample size when separated and because the NHAMCS combines these into 1 “general practitioner” category. Of the outpatient visits to family practice physicians or internists (from the NAMCS), only 18% were to internists (most for those >17 years) and 82% to family practice physicians. Preventive visits to subspecialists were excluded because there were substantially fewer than 30 visits for each age group and sex.
Vaccination visits included diphtheria-tetanus (Td), measles-mumps-rubella (MMR), and hepatitis B vaccination, as designated by visit-specific codes for Td (09815, 09820, 09900, 09905, 09990, 09993, 31005, and 31015), hepatitis B (92131 and 96049), and MMR (18100, 18540, and 27075). Varicella vaccine was coded (02396) at only 21 visits, so these visits were not examined.
We used χ2 tests to determine statistical differences between the samples of office-based and hospital-based visits based on stage of adolescence (early: 11-14 years; middle: 15-17 years; and late: 18-21 years)7 and sex and to compare, by adolescent age and sex, the type of health care professional seen for all visits, preventive care visits, and vaccination-related visits. These tests were also used to determine differences in patient demographics and visit types to pediatricians compared with family physicians. Regression analyses were used to determine characteristics of visits to pediatricians vs family physicians. Trend analyses were performed through 2002 to determine if there were significant differences in physician type for overall visits by stage of adolescence over time, as well as for the proportion of preventive visits over time. We excluded data from 2003 for trend analyses because of changes in the survey methods that make these data incomparable for trends.30 SUDAAN statistical software version 9.0 was used to account for the sampling design of the surveys.31
Number of outpatient visits
Adolescents accounted for 9.1% of all outpatient visits in the United States from 1994 to 2003, although they comprised 15.7% of the US population in 2000.32 Adolescents made an average of 80 million outpatient visits per year during this time, with 70 million visits to office-based practices and almost 10 million visits to hospital-based ones. Outpatient visits for adolescents increased by 33% throughout the decade (from 69 million in 1994 to 92 million in 2003).
Demographic characteristics
Eighty-eight percent of the sample represents visits to office-based (NAMCS) rather than hospital-based practices (NHAMCS) (Table 1). Adolescents seen in hospital-based settings were more likely to be black (24%), to be female (62%), and to have Medicaid coverage (35%) than those seen in office-based settings (10%, 16%, and 57%, respectively; P<.001 for all). The remainder of the results refer to the combined data sets.
Outpatient visits by age and sex
Adolescent males had fewer health care visits at older ages, with a sharp decline in visits after the age of 16 years, whereas adolescent females had a greater number of visits at older ages (Figure 1). In early adolescence, both sexes had a similar volume of visits by age (3.3 million for 11-year-old girls and 3.7 million for 11-year-old boys), whereas in later adolescence females had far more outpatient visits than males did (5 million for 21-year-old females and 1.8 million for 21-year-old males).
Outpatient visits by physician type
Forty percent of outpatient visits for adolescents up to the age of 14 years were to pediatricians; however, pediatricians had a gradually decreasing role in primary care for adolescents older than 14 years. They provided a small proportion of visits for adolescents 18 years and older (4% of female visits and 7% of male visits). Family practice physicians in private offices remained fairly constant as health care providers for both sexes but performed a greater proportion of visits for older males (22% of early and 29% of late adolescent boy visits; P<.001). Internists in private offices provided a small percentage of adolescent visits overall, and as expected, visits to these offices increased with age (4% of early and 7% of late adolescent girl visits and 3% of early and 10% of late adolescent boy visits).
Subspecialists were seen for 27% of visits overall, with the greatest proportion of visits among late adolescent males (46%). Orthopedists, dermatologists, and psychiatrists were the most commonly visited subspecialists (20%, 19%, and 12% of subspecialty visits, respectively), together accounting for approximately half of all subspecialty visits made by adolescents. After the age of 18 years, females had more visits to obstetrician-gynecologists than any other type of physician (36% of late adolescent female visits).
Preventive visits made by females declined moderately after the age of 14 years and declined further after the age of 17 years (P<.001 by age group) (Figure 2). Preventive visits made by males declined somewhat after the age of 13 years and again more substantially after the age of 17 years (P<.001 by age group). More than 3 times as many preventive visits were made by early adolescents than by late adolescents (P<.001).
Most preventive visits for adolescents 14 years and younger (59% of visits for girls and 66% for boys) and almost half of preventive visits among middle adolescents were to pediatricians (41% of female and 46% of male visits). Pediatricians provided a much smaller share of preventive care to late adolescents (12% of female and 13% of male visits). Family practice physicians and internists performed the remainder of preventive visits for early adolescents (39% of female and 32% of male visits) and provided most of the preventive care visits to late adolescents (50% of female and 70% of male visits). Thirty-five percent of preventive visits made by late adolescent females (for well-adolescent care, not prenatal care) were to obstetrician-gynecologists.
Overall, only 9% of all adolescent visits were for preventive care (Figure 3). Preventive visits comprised a somewhat higher proportion of visits for early adolescent boys and girls (13% of visits for both) than for late adolescents (P<.001). Late adolescent males had the fewest preventive visits, with only 509 000 visits per year (6% of visits by males). The greatest proportion of visits overall was for late adolescent females, but only 3% of those were for preventive care (690 000 visits per year). Compared with population estimates from the 2000 census, only 16% of adolescents overall had preventive care visits.32
Predictors of physician type seen (pediatrician vs family practice physician)
In bivariate analyses (Table 2), significant differences (P<.001) were found in the physician type (pediatrician vs family physician) seen for overall visits by age group, sex, race, insurance type, metropolitan statistical area, and visit type (preventive visit vs other). In multivariate analyses (Table 3), visits to pediatricians were more likely to be made by younger and middle adolescents (odds ratio [OR], 7.9 and 4.1, respectively), black adolescents (OR, 1.7), and those from urban areas (OR, 3.4). Preventive visits were more likely made to pediatricians (OR, 1.5) than to family practice physicians. Family practice physicians were more likely to see adolescent females and individuals who paid out of pocket for health care.
These analyses used 9 years of data from both surveys to examine time trends in patterns of visits by adolescent age and sex and by type of physician seen. Middle adolescents made fewer visits to family practices over time (P = .004 for girls and P = .05 for boys), but no significant trends were found for early or late adolescents. Middle adolescent girls also had more visits to pediatricians over time (P = .003) and fewer visits to obstetrician-gynecologists (P = .05). No significant change was found in the proportion of preventive care visits during the period examined.
Vaccination-related visits
Adolescents generally received vaccinations during preventive visits. Preventive care visits accounted for 80% of visits that included MMR, 70% that included hepatitis B, and 64% of visits that included Td vaccinations. Diagnosis codes at visits that included Td vaccination included laceration, animal bite, and puncture wounds. As expected, early adolescents received most of the vaccinations (MMR, 76%; hepatitis B, 67%; and Td, 56%), and most were received at visits to pediatricians (MMR, 61%; hepatitis B, 72%; and Td, 57%). Adolescents rarely received immunizations from obstetrician-gynecologists or subspecialists (1%-3%).
New and emerging vaccines for adolescents require a reassessment of current adolescent health care utilization, which reflects the types of physicians who should be responsible for vaccine delivery within existing care patterns. Our results show that for both overall care and preventive visits, younger adolescents primarily visit pediatricians, whereas older adolescents make more outpatient visits to family practice physicians and internists. During a 9-year period, visits to pediatricians by middle adolescents increased with time and those to family practice physicians declined. Among late-adolescent females, a larger proportion of visits were to obstetrician-gynecologists. Adolescents typically received immunizations at preventive visits and rarely during visits to obstetrician-gynecologists or subspecialists. Preventive visits make up only a small percentage of outpatient visits by adolescents and occur less frequently among older adolescents, suggesting that vaccines targeted to late adolescents may be unlikely to reach most teens if vaccination remains coupled with preventive care.
To best deliver vaccines to adolescents within current health care visit patterns, vaccination before late adolescence is optimal. Not only are there more preventive visits among adolescents before the age of 15 years, but those visits are to traditional immunization providers (eg, pediatricians and family practice physicians), who more often perform these services than do most subspecialists. These findings complement early evidence on human papillomavirus vaccine, which showed that vaccinating at younger rather than older adolescent ages offers a heightened immune response and that the vaccine is most effective if delivered before sexual activity occurs.33,34
A prior analysis of the 1994 NAMCS also noted a predominance of visits to pediatricians among early adolescents,35 but our study adds to existing knowledge by examining multiple visit types, identifying vaccination-related visits, and including visits to hospital-based outpatient settings that serve a significant proportion of low-income patients. Studies36-39 show that physicians' attitudes, recommendations, and specialty are predictors of immunization status. Our study and others40 have shown that family practice physicians play an important role in the care of adolescents, particularly as they approach early adulthood. Historically, some differences have been noted between pediatricians and family practice physicians in terms of perceptions and delivery of vaccinations. One study41 found that, compared with pediatricians, family practice physicians reported more barriers when vaccinating older adolescents. Others have found that pediatricians were more likely than family practice physicians to track undervaccinated children42 and adolescents,43 to use acute care visits as opportunities to vaccinate, and to participate in immunization registries.44 At the same time, most visits by minority and urban populations are to pediatricians, and because immunization coverage among these populations has tended to be lower,45 pediatricians have a special role in vaccinating high-risk populations and reducing disparities in coverage. Therefore, it will be critical for professional organizations such as the American Academy of Pediatrics, American Academy of Family Physicians, and American College of Obstetricians and Gynecologists to provide intensive, specialty-specific outreach and communication with their members to maximize delivery of new vaccines to their adolescent patients, particularly those populations that remain traditionally underimmunized.
We found that a large proportion of visits among older adolescent females seen by obstetrician-gynecologists was for preventive visits and not for prenatal care, with a simultaneous decline in overall visits to obstetrician-gynecologists observed during 9 years. This finding may be reflective of the decline in adolescent pregnancies during the same interval. The role of obstetrician-gynecologists in providing primary care has evolved in recent years. As of 2003, 40 states had mandates allowing women direct access to obstetrician-gynecologist care rather than requiring a gatekeeper, and 17 had mandates that obstetrician-gynecologists can act as primary care physicians.46 In a 2000 survey of obstetrician-gynecologists, 47% identified themselves as primary care physicians, yet only 10% thoroughly assessed their patients for vaccine-preventable diseases.47 If vaccines are offered to older adolescents or catch-up vaccines are recommended for older adolescents, education of obstetrician-gynecologists in the delivery of these vaccines is important.
Some have suggested that adolescent vaccinations may be provided by specialists; however, the most common specialists treating adolescents are orthopedists, dermatologists, and psychiatrists. Since none of these groups are accustomed to providing vaccinations, a widespread program of adolescent vaccination by specialists does not appear feasible. Further studies are needed to assess how many adolescents who see specialists do not see primary care physicians.
The proportion of adolescent visits that were preventive care visits was surprisingly small. An annual preventive care visit to a health care professional is important to deliver recommended preventive services.7,8 Among younger children, underimmunization is a marker of lack of receipt of other preventive services,48 and focusing on immunizations has helped increase other aspects of preventive care.49 It is possible that a similar spillover effect could occur among adolescents. Ensuring that adolescents receive annual preventive visits should be a priority of primary care physicians, and incorporating strategies such as patient reminder or recall50-52 to increase preventive visits and vaccinations is particularly important for this age group. Tracking adolescents with an immunization registry so that vaccines received in different settings could be recorded might make secondary care physicians more likely to offer vaccines.41
Physicians currently provide almost all MMR and hepatitis B vaccinations at preventive care visits. Even for Td vaccine, which is often provided at injury-related visits, two thirds of outpatient vaccinations (not including those given in emergency departments) were provided during preventive visits. Inclusion of acute care visits as potential opportunities for vaccination could improve the coverage rates for new adolescent vaccines. To increase early childhood immunization rates during the past decade, emphasis has been placed on providing vaccines to young children at illness visits to avoid missed opportunities.15,53,54 However, as of 1997, only 24% of pediatricians and family practice physicians in the United States reported immunizing adolescents at acute care visits.43 Although our ultimate goal is for all adolescents to have annual preventive visits, until that goal can be reached it is important to deliver vaccinations at all possible opportunities. In addition, human papillomavirus vaccination will require multiple follow-up visits to complete the series, heightening the need to use all visits as vaccination opportunities.
The NAMCS and NHAMCS databases are visit-based surveys. Longitudinal analyses that link individuals over time are not possible, and individuals without any health care visits are not included. For the 12% of outpatient visits obtained from the NHAMCS database, we were unable to differentiate family practice physicians from internists. Thus, we examined the data from the NAMCS database separately to better distinguish family practice physicians from internists in the care of adolescents. For preventive care, internist visits were too infrequent to provide reliable estimates, but we would not expect internists to care for many adolescents younger than 18 years, who made 63% of the adolescent visits within the NHAMCS. Finally, visit definitions for preventive visits are limited by physician documentation of diagnoses, so misclassifications are possible. However, physicians are trained in how to fill out the visit-based forms and are instructed to include all diagnoses appropriate for each visit.
We conclude the following:
As adolescents age into their late teens, visits to primary care physicians decline substantially, reducing opportunities for immunizations.
Pediatricians provided most of the outpatient visits for young adolescents, black adolescents, and those from urban areas but markedly fewer visits for older adolescents.
Family practice physicians play a large role in caring for adolescents of all ages (particularly older ones), and obstetrician-gynecologists provide the greatest number of visits for females older than 18 years.
Preventive visits make up a small proportion of all visits and an increasingly smaller proportion of visits for older adolescents.
Vaccinations are provided almost exclusively during preventive visits.
The implications are as follows:
Adolescents should preferably be vaccinated during early or middle adolescence, when they are most likely to visit pediatricians and family practice physicians and far more likely to have preventive visits than older teens.
Education and outreach to all physicians who are major providers of adolescent care are important to ensure that new vaccines are delivered routinely in all health care settings.
The practice of vaccinating at acute care visits should be extended to adolescents to take advantage of every opportunity to provide immunizations.
Physicians should incorporate strategies to bring in adolescents for annual preventive visits to deliver recommended preventive services, including new adolescent vaccinations.
By capitalizing on adolescent health care utilization patterns and incorporating strategies proven for infants to improve immunization delivery, our health care system should be able to integrate new adolescent vaccinations into efforts to improve overall adolescent preventive services.
Correspondence: Cynthia M. Rand, MD, MPH, Division of General Pediatrics, Box 777, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642 (cynthia_rand@urmc.rochester.edu).
Accepted for Publication: September 5, 2006.
Author Contributions:Study concept and design: Rand, Shone, and Szilagyi. Acquisition of data: Rand and Auinger. Analysis and interpretation of data: Rand, Shone, Albertin, Auinger, and Klein. Drafting of the manuscript: Rand and Szilagyi. Critical revision of the manuscript for important intellectual content: Rand, Shone, Albertin, Auinger, and Klein. Statistical analysis: Rand, Auinger, Klein, and Szilagyi. Obtained funding: Rand and Szilagyi. Administrative, technical, and material support: Shone, Albertin, and Szilagyi. Study supervision: Klein.
Financial Disclosure: None reported.
Funding/Support: This study was supported under cooperative agreement U01IP000040 from the Centers for Disease Control and Prevention.
Previous Presentation: This study was presented in part at the Pediatric Academic Societies' Annual Meeting; Washington, DC; May 16, 2005.
1.Centers for Disease Control and Prevention, Ten great public health achievements—United States, 1900-1999.
MMWR Morb Mortal Wkly Rep 1999;48241- 243
PubMedGoogle Scholar 2.Hopkins
RSJajosky
RAHall
PA
et al. Summary of notifiable diseases—United States, 2003.
MMWR Morb Mortal Wkly Rep 2005;521- 85
PubMedGoogle Scholar 3.Kaplan
SLMason
EO
JrWald
E
et al. Six year multicenter surveillance of invasive pneumococcal infections in children.
Pediatr Infect Dis J 2002;21141- 147
PubMedGoogle ScholarCrossref 4.Kaplan
SLMason
EO
JrWald
ER
et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
Pediatrics 2004;113443- 449
PubMedGoogle ScholarCrossref 5.Flannery
BSchrag
SBennett
NM
et al. Impact of childhood vaccination on racial disparities in invasive
Streptococcus pneumoniae infections.
JAMA 2004;2912197- 2203
PubMedGoogle ScholarCrossref 6.Whitney
CGFarley
MMHadler
J
et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
N Engl J Med 2003;3481737- 1746
PubMedGoogle ScholarCrossref 7.National Center for Education in Maternal and Child Health, Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents. 2nd ed Arlington, Va National Center for Education in Maternal and Child Health2002;
8.Elster
ABKuznets
NJ AMA Guidelines for Adolescent Preventive Services (GAPS): Recommendations and Rationale. Baltimore, Md Williams and Wilkins1994;
9.Gadomski
ABennett
SYoung
MWissow
LS Guidelines for Adolescent Preventive Services: the GAPS in practice.
Arch Pediatr Adolesc Med 2003;157426- 432
PubMedGoogle ScholarCrossref 10.Klein
JDAllan
MJElster
AB
et al. Improving adolescent preventive care in community health centers.
Pediatrics 2001;107318- 327
PubMedGoogle ScholarCrossref 11.Bilukha
OORosenstein
N Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep 2005;541- 21
PubMedGoogle Scholar 13.Southern
JAndrews
NBurrage
MMiller
E Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers.
Vaccine 2005;233829- 3835
PubMedGoogle ScholarCrossref 14.Yu
SMBellamy
HASchwalberg
RHDrum
MA Factors associated with use of preventive dental and health services among U.S. adolescents.
J Adolesc Health 2001;29395- 405
PubMedGoogle ScholarCrossref 15.Burstein
GRLowry
RKlein
JDSantelli
JS Missed opportunities for sexually transmitted diseases, human immunodeficiency virus, and pregnancy prevention services during adolescent health supervision visits.
Pediatrics 2003;111996- 1001
PubMedGoogle ScholarCrossref 16.Klein
JDMcNulty
MFlatau
CN Adolescents' access to care: teenagers' self-reported use of services and perceived access to confidential care.
Arch Pediatr Adolesc Med 1998;152676- 682
PubMedGoogle ScholarCrossref 17.Elster
AJarosik
JVanGeest
JFleming
M Racial and ethnic disparities in health care for adolescents: a systematic review of the literature.
Arch Pediatr Adolesc Med 2003;157867- 874
PubMedGoogle ScholarCrossref 18.Newacheck
PWHung
YYPark
MJBrindis
CDIrwin
CE
Jr Disparities in adolescent health and health care: does socioeconomic status matter?
Health Serv Res 2003;381235- 1252
PubMedGoogle ScholarCrossref 19.Galbraith
AAStevens
JKlein
JD Health care access and utilization among pregnant adolescents.
J Adolesc Health 1997;21253- 258
PubMedGoogle ScholarCrossref 21.Klein
JDWilson
KMMcNulty
MKapphahn
CCollins
KS Access to medical care for adolescents: results from the 1997 Commonwealth Fund Survey of the Health of Adolescent Girls.
J Adolesc Health 1999;25120- 130
PubMedGoogle ScholarCrossref 22.Marcell
AVKlein
JDFischer
IAllan
MJKokotailo
PK Male adolescent use of health care services: where are the boys?
J Adolesc Health 2002;3035- 43
PubMedGoogle ScholarCrossref 23.Civic
DScholes
DGrothaus
LMcBride
C Adolescent HMO enrollees' utilization of out-of-plan services.
J Adolesc Health 2001;28491- 496
PubMedGoogle ScholarCrossref 24.Dey
ANBloom
B Summary health statistics for U.S. children: National Health Interview Survey, 2003.
Vital Health Stat 10 2005;2231- 87
PubMedGoogle Scholar 25.Bryant
EShimizu
I Sample design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey.
Vital Health Stat 2 1988;1081- 39
PubMedGoogle Scholar 26.McCaig
LFMcLemore
T Plan and operation of the National Hospital Ambulatory Medical Care Survey, series 1: programs and collection procedures.
Vital Health Stat 1 1994;341- 78
PubMedGoogle Scholar 27.World Health Organization, International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland World Health Organization1977;
31.Research Triangle Institute, SUDAAN Language Manual. Release 9.0 ed Research Triangle Park, NC Research Triangle Institute2006;
33.Block
SLNolan
TSattler
CProtocol 016 Study Group, Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.
Pediatrics 2006;1182135- 2145
PubMedGoogle ScholarCrossref 34.Mao
CKoutsky
LAAult
KA
et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.
Obstet Gynecol 2006;10718- 27
PubMedGoogle ScholarCrossref 36.Szilagyi
PGRoghmann
KJCampbell
JR
et al. Immunization practices of primary care practitioners and their relation to immunization levels.
Arch Pediatr Adolesc Med 1994;148158- 166
PubMedGoogle ScholarCrossref 37.Taylor
JADarden
PMSlora
EHasemeier
CMAsmussen
LWasserman
R The influence of provider behavior, parental characteristics, and a public policy initiative on the immunization status of children followed by private pediatricians: a study from Pediatric Research in Office Settings.
Pediatrics 1997;99209- 215
PubMedGoogle ScholarCrossref 38.Koepke
CPVogel
CAKohrt
AE Provider characteristics and behaviors as predictors of immunization coverage.
Am J Prev Med 2001;21250- 255
PubMedGoogle ScholarCrossref 39.Nichol
KLMac
DRHauge
M Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults.
J Gen Intern Med 1996;11673- 677
PubMedGoogle ScholarCrossref 40.Freed
GLNahra
TAWheeler
JR Which physicians are providing health care to America's children? trends and changes during the past 20 years.
Arch Pediatr Adolesc Med 2004;15822- 26
PubMedGoogle ScholarCrossref 41.Oster
NVMcPhillips-Tangum
CAAverhoff
FHowell
K Barriers to adolescent immunization: a survey of family physicians and pediatricians.
J Am Board Fam Pract 2005;1813- 19
PubMedGoogle ScholarCrossref 42.Szilagyi
PGRodewald
LEHumiston
SG
et al. Immunization practices of pediatricians and family physicians in the United States.
Pediatrics 1994;94517- 523
PubMedGoogle Scholar 43.Schaffer
SJHumiston
SGShone
LPAverhoff
FMSzilagyi
PG Adolescent immunization practices: a national survey of US physicians.
Arch Pediatr Adolesc Med 2001;155566- 571
PubMedGoogle ScholarCrossref 45.Chu
SYBarker
LESmith
PJ Racial/ethnic disparities in preschool immunizations: United States, 1996-2001.
Am J Public Health 2004;94973- 977
PubMedGoogle ScholarCrossref 47.Gonik
BJones
TContreras
DFasano
NRoberts
C The obstetrician-gynecologist's role in vaccine-preventable diseases and immunization.
Obstet Gynecol 2000;9681- 84
PubMedGoogle ScholarCrossref 48.Rodewald
LESzilagyi
PGShiuh
THumiston
SGLeBaron
CHall
CB Is underimmunization a marker for insufficient utilization of preventive and primary care?
Arch Pediatr Adolesc Med 1995;149393- 397
PubMedGoogle ScholarCrossref 49.Rodewald
LESzilagyi
PGHumiston
SGBarth
RKraus
RRaubertas
RF A randomized study of tracking with outreach and provider prompting to improve immunization coverage and primary care.
Pediatrics 1999;10331- 38
PubMedGoogle ScholarCrossref 50.Szilagyi
PGBordley
CVann
JC
et al. Effect of patient reminder/recall interventions on immunization rates: a review.
JAMA 2000;2841820- 1827
PubMedGoogle ScholarCrossref 51.Szilagyi
PGSchaffer
SBarth
R
et al. Effect of telephone reminder/recall on adolescent immunization and preventive visits: results from a randomized clinical trial.
Arch Pediatr Adolesc Med 2006;160157- 163
PubMedGoogle ScholarCrossref 52.Shefer
ASantoli
JWortley
P
et al. Status of quality improvement activities to improve immunization practices and delivery: findings from the immunization quality improvement symposium, October 2003.
J Public Health Manag Pract 2006;1277- 89
PubMedGoogle ScholarCrossref 54.Szilagyi
PGRodewald
LE Missed opportunities for immunizations: a review of the evidence.
J Public Health Manag Pract 1996;218- 25
PubMedGoogle ScholarCrossref